Aggregator
El Niños that linger are becoming less of a rarity
Author Correction: Isoprene nitrates drive new particle formation in Amazon’s upper troposphere
Superpowers want to control critical mineral supplies — local communities need a stronger say
How Europe aims to woo US scientists and protect academic freedom
A brain drain would impoverish the United States and diminish world science
Deadly Myanmar earthquake was probably a rare rupture, scientists say
How to get rid of toxic ‘forever chemical’ pollution
How seahorses and pipefish inspired the design of a boat propeller
Author Correction: Controlled patterning of crystalline domains by frontal polymerization
Pathways that limit differentiation of oligodendrocyte progenitors in the aging brain
The advantages and challenges of disability-free survival as outcome measure in clinical studies
Action needed to mitigate effects of slashing USAID
The global scientific community must keep studying LGBT+ health
China has already taken steps to reduce retractions of papers from its hospitals
Minerals will shape future geopolitical order
I went to a physics conference—and a hockey game broke out
Hockey-loving physicists from around the world lug their stinky gear to play at the American Physical Society’s annual meeting
Trump administration purges U.S. health agency leaders
Reassignment letters come as reductions in force begin at NIH, FDA, and CDC
Molecular ‘staples’ resolve puzzle of how collagen stays together
Research reveals how the key structural protein, inherently unstable at body temperature, forms resilient twists
Efficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer's disease: A systematic review and meta-analysis
CONCLUSIONS: Anti-Aβ mAb therapy slows cognitive decline, but with small effect sizes, and raises potential concerns about ARIA and headaches.
A review: From old drugs to new solutions: The role of repositioning in alzheimer's disease treatment
Drug repositioning or drug reprofiling, involves identifying novel indications for approved and previously abandoned drugs in the treatment of other diseases. The traditional drug discovery process is tedious, time-consuming, risky, and challenging. Fortunately, the inception of the drug repositioning concept has expedited the process by using compounds with established safety profiles in humans, and thereby significantly reducing costs. Alzheimer's disease (AD) is a severe neurological disorder...